Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Kenvue Inc. (KVUE : NYSE)

• Company Description    Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J. Number of Employees: 22,000

• Price / Volume Information    Yesterday's Closing Price: $17.79 Daily Weekly Monthly 20 Day Moving Average: 21,945,646 shares Shares Outstanding: 1,920.77 (millions) Market Capitalization: $34,170.56 (millions) Beta: 0.46 52 Week High: $20.13 52 Week Low: $14.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -7.34% -4.81% 12 Week -1.82% -3.00% Year To Date 3.13% -7.01%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1 KENVUE WAY - SUMMIT,NJ 07901 USA ph: 908-874-1200 fax: - kenvue_ir@kenvue.com http://www.kenvue.com

• General Corporate Information    Officers Kirk L. Perry - Chief Executive Officer Larry J. Merlo - Chairman Amit Banati - Chief Financial Officer Michael E. Sneed - Director Jeffrey C. Smith - Director Peer Information Kenvue Inc. (EPC) Kenvue Inc. (HPPS) Kenvue Inc. (ADRNY) Kenvue Inc. (YHGJ) Kenvue Inc. (GPSYY) Kenvue Inc. (HENKY) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: CONS PD- MISC STPL Sector: Consumer Staples CUSIP: 49177J102 SIC: 2844 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/02/26 Share - Related Items Shares Outstanding: 1,920.77 Most Recent Split Date: (:1) Beta: 0.46 Market Capitalization: $34,170.56 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 4.72% Current Fiscal Quarter EPS Consensus Estimate: $0.28 Indicated Annual Dividend: $0.84 Current Fiscal Year EPS Consensus Estimate: $1.14 Payout Ratio: 0.70 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: -0.02 Estmated Long-Term EPS Growth Rate: 9.81% Last Dividend Paid: 08/12/2026 - $0.21 Next EPS Report Date: 11/02/26

• Fundamental Ratios P/E Current FY Estimate: 15.55 Trailing 12 Months: 15.08 PEG Ratio: 1.59 Price Ratios Price/Book: 3.24 Price/Cash Flow: 12.90 Price / Sales: 2.22 EPS Growth vs. Year Ago Period: 6.90% vs. Previous Quarter: -3.12% Sales Growth vs. Year Ago Period: 3.02% vs. Previous Quarter: 1.18% ROE 06/30/26 - 21.22 03/31/26 - 20.81 12/31/25 - 19.72 ROA 06/30/26 - 8.37 03/31/26 - 8.21 12/31/25 - 7.72 Current Ratio 06/30/26 - 1.01 03/31/26 - 0.98 12/31/25 - 0.96 Quick Ratio 06/30/26 - 0.71 03/31/26 - 0.70 12/31/25 - 0.68 Operating Margin 06/30/26 - 14.66 03/31/26 - 14.54 12/31/25 - 13.75 Net Margin 06/30/26 - 10.76 03/31/26 - 10.61 12/31/25 - 9.72 Pre-Tax Margin 06/30/26 - 14.43 03/31/26 - 14.47 12/31/25 - 13.22 Book Value 06/30/26 - 5.50 03/31/26 - 5.53 12/31/25 - 5.62 Inventory Turnover 06/30/26 - 3.76 03/31/26 - 3.69 12/31/25 - 3.66 Debt-to-Equity 06/30/26 - 0.67 03/31/26 - 0.67 12/31/25 - 0.66 Debt-to-Capital 06/30/26 - 40.13 03/31/26 - 40.00 12/31/25 - 39.65

Powered by Zacks Investment Research ©